Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Foresite Capital Fund IV, L.P.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-02-27
Sale
2020-03-02
5:01 pm
AERIE PHARMACEUTICALS INCAERIForesite Capital Management II LLC
Foresite Capital Fund II L.P.
Foresite Capital Fund III L.P.
Foresite Capital Fund IV L.P.
Foresite Capital Management III LLC
Foresite Capital Management IV LLC
Tananbaum James B.
10% Owner
1,000,000$17.07$17,070,0001,229,633
(Indirect)
View
2019-09-04
Purchase
2019-09-06
8:28 pm
AERIE PHARMACEUTICALS INCAERIForesite Capital Management II LLC
Foresite Capital Fund II L.P.
Foresite Capital Management III LLC
Foresite Capital Fund III L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
115,900$18.47$2,140,8902,350,477
(Indirect)
View
2019-08-30
Purchase
2019-09-04
8:38 pm
AERIE PHARMACEUTICALS INCAERIForesite Capital Management II LLC
Foresite Capital Fund II L.P.
Foresite Capital Management III LLC
Foresite Capital Fund III L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
75,000$21$1,574,7412,325,477
(Indirect)
View
2019-08-21
Purchase
2019-08-23
8:52 pm
AERIE PHARMACEUTICALS INCAERIForesite Capital Management II LLC
Foresite Capital Fund II L.P.
Foresite Capital Management III LLC
Foresite Capital Fund III L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
46,153$23.45$1,082,4492,250,477
(Indirect)
View
2019-08-16
Purchase
2019-08-20
8:27 pm
AERIE PHARMACEUTICALS INCAERIForesite Capital Management II LLC
Foresite Capital Fund II L.P.
Foresite Capital Management III LLC
Foresite Capital Fund III L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
153,847$23.88$3,673,2892,204,324
(Indirect)
View
2019-08-12
Purchase
2019-08-14
8:15 pm
AERIE PHARMACEUTICALS INCAERIForesite Capital Management II LLC
Foresite Capital Fund II L.P.
Foresite Capital Management III LLC
Foresite Capital Fund III L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
539,555$24.73$13,341,1702,050,477
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-11-01
Other
2021-11-03
4:17 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSForesite Capital Management III LLC
Foresite Capital Fund III L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Tananbaum James B.
10% Owner
1,963,180$06,628,733
(Indirect)
View
2021-02-05
Ownership
2021-02-10
6:00 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSForesite Capital Management III LLC
Foresite Capital Fund III L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Tananbaum James B.
10% Owner
0$06,612,181
(Indirect)
View
2020-12-07
Conversion
2020-12-09
1:35 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Management V LLC
Foresite Capital Opportunity Fund V L.P.
10% Owner
19,675,448$0291,667
(Indirect)
View
2020-12-03
Option Award
2020-12-04
8:57 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Management V LLC
Foresite Capital Opportunity Fund V L.P.
10% Owner
1,000,000$20125,000
(Indirect)
View
2020-12-02
Ownership
2020-12-03
06:03 am
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Management V LLC
Foresite Capital Opportunity Fund V L.P.
10% Owner
0$09,838,311
(Indirect)
View
2019-12-20
Exercise
2019-12-23
6:05 pm
N/A
2019-12-20
AERIE PHARMACEUTICALS INCAERIForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
289$05,524,591
(Indirect)
View
2019-12-20
Exercise
2019-12-23
6:05 pm
N/A
N/A
AERIE PHARMACEUTICALS INCAERIForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
28,900$305,524,591
(Indirect)
View
2019-11-26
Exercise
2019-12-05
7:03 pm
N/A
2019-12-20
AERIE PHARMACEUTICALS INCAERIForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
310$05,496,535
(Indirect)
View
2019-11-26
Exercise
2019-12-05
7:03 pm
N/A
N/A
AERIE PHARMACEUTICALS INCAERIForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
31,000$305,496,535
(Indirect)
View
2019-11-14
Exercise
2019-11-18
6:11 pm
N/A
2019-12-20
AERIE PHARMACEUTICALS INCAERIForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
256$05,466,088
(Indirect)
View
2019-11-14
Exercise
2019-11-18
6:11 pm
N/A
N/A
AERIE PHARMACEUTICALS INCAERIForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
25,600$305,466,088
(Indirect)
View
2019-11-07
Exercise
2019-11-12
2:52 pm
N/A
2019-12-20
AERIE PHARMACEUTICALS INCAERIForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
150$05,439,946
(Indirect)
View
2019-11-07
Exercise
2019-11-12
2:52 pm
N/A
N/A
AERIE PHARMACEUTICALS INCAERIForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
15,000$305,439,946
(Indirect)
View
2019-08-12(A)
Ownership
2019-11-05
7:14 pm
N/A
N/A
AERIE PHARMACEUTICALS INCAERIForesite Capital Management II LLC
Foresite Capital Fund II L.P.
Foresite Capital Management III LLC
Foresite Capital Fund III L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
0$04,594,136
(Indirect)
View
2019-09-11
Ownership
2019-09-11
8:19 pm
N/A
N/A
10x Genomics Inc.TXGForesite Capital Management I LLC
Foresite Capital Fund I L.P.
Foresite Capital Management II LLC
Foresite Capital Fund II L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
0$013,885,149
(Indirect)
View
2019-08-12
Ownership
2019-08-14
8:14 pm
N/A
N/A
AERIE PHARMACEUTICALS INCAERIForesite Capital Management II LLC
Foresite Capital Fund II L.P.
Foresite Capital Management III LLC
Foresite Capital Fund III L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Tananbaum James B.
10% Owner
0$04,594,136
(Indirect)
View
(A) Indicate amendment filing.